Predicting Neoadjuvant Chemotherapy Response by Using a Combined MRI and Scinti-Mammography (MRI-SMM) System

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this research study is to investigate the accuracy of a breast imaging system that measures the uptake of the injected radioactive tracer by gamma-ray imaging, known as scinti-mammography (SMM), to diagnose the residual breast cancer after neoadjuvant chemotherapy (NAC) treatment by comparing to MRI.
Epistemonikos ID: b7c8be2a17e8d0601db4d39c0ed2f167fe87e5e6
First added on: May 12, 2024